首页> 外文期刊>Stem cells and development >Phenotypic and functional analysis of human fetal liver hematopoietic stem cells in culture.
【24h】

Phenotypic and functional analysis of human fetal liver hematopoietic stem cells in culture.

机译:人胎肝造血干细胞培养的表型和功能分析。

获取原文
获取原文并翻译 | 示例
       

摘要

Steady-state hematopoiesis and hematopoietic transplantation rely on the unique potential of stem cells to undergo both self-renewal and multilineage differentiation. Fetal liver (FL) represents a promising alternative source of hematopoietic stem cells (HSCs), but limited by the total cell number obtained in a typical harvest. We reported that human FL nonobese diabetic/severe combined immunodeficient (NOD/SCID) repopulating cells (SRCs) could be expanded under simple stroma-free culture conditions. Here, we sought to further characterize FL HSC/SRCs phenotypically and functionally before and following culture. Unexpanded or cultured FL cell suspensions were separated into various subpopulations. These were tested for long-term culture potential and for in vivo repopulating function following transplantation into NOD/SCID mice. We found that upon culture of human FL cells, a tight association between classical stem cell phenotypes, such as CD34(+) /CD38(-) and/or side population, and NOD/SCID repopulating function was lost, as observed with other sources. Although SRC activity before and following culture consistently correlated with the presence of a CD34(+) cell population, we provide evidence that, contrary to umbilical cord blood and adult sources, stem cells present in both CD34(+) and CD34(-) FL populations can sustain long-term hematopoietic cultures. Furthermore, upon additional culture, CD34-depleted cell suspensions, devoid of SRCs, regenerated a population of CD34(+) cells possessing SRC function. Our studies suggest that compared to neonatal and adult sources, the phenotypical characteristics of putative human FL HSCs may be less strictly defined, and reinforce the accumulated evidence that human FL represents a unique, valuable alternative and highly proliferative source of HSCs for clinical applications.
机译:稳态造血和造血移植依靠干细胞独特的潜能来进行自我更新和多系分化。胎儿肝脏(FL)代表造血干细胞(HSC)的有希望替代来源,但受到典型收获中获得的总细胞数的限制。我们报道了人类FL非肥胖糖尿病/重症联合免疫缺陷(NOD / SCID)再生细胞(SRC)可以在无基质的简单培养条件下扩增。在这里,我们试图在培养前后,通过表型和功能进一步鉴定FL HSC / SRC。未扩增或培养的FL细胞悬浮液被分为不同的亚群。在移植到NOD / SCID小鼠中后,对它们的长期培养潜力和体内再填充功能进行了测试。我们发现,在培养人类FL细胞后,经典干细胞表型(例如CD34(+)/ CD38(-)和/或侧群)与NOD / SCID的重新填充功能之间的紧密联系就消失了,正如其他来源所观察到。尽管培养前后的SRC活性与CD34(+)细胞群体的存在始终相关,但我们提供的证据表明,与脐带血和成人来源相反,CD34(+)和CD34(-)FL中均存在干细胞人群可以维持长期的造血文化。此外,通过额外的培养,不含SRC的CD34耗尽的细胞悬浮液可再生具有SRC功能的CD34(+)细胞。我们的研究表明,与新生儿和成人来源相比,推定的人类FL HSC的表型特征可能没有那么严格的定义,并且强化了积累的证据,即人类FL代表了临床应用中HSC的独特,有价值的替代性和高度增殖性来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号